Select Options
News
results
Page of
Baker Botts Welcomes Prominent Cross-Border M&A Partner in New York
FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics
Wall Street JournalWall Street Journal
Baker Botts Represents Stoller Group’s Trustees in Sale to Corteva Agriscience
Baker Botts Represents Celanese in $11 Billion Acquisition of DuPont's Mobility and Materials Business
Legal 500 US and Chambers USA 2022 Rankings Highlight Baker Botts’ Technology Expertise
Baker Botts Elects 18-Member Partnership Class
Baker Botts Advises Viracorp On Partnership with Lancaster University to Produce New Nasal COVID-19 Vaccine
Baker Botts Achieves Favorable ITC Final Determination for CMC Materials
Baker Botts Welcomes Financial Restructuring Partner in New York
Baker Botts Advises Resilia Pharmaceuticals, Inc. in License Agreement for Solace Eczema Cream
Baker Botts Improves Rankings and Individual Recognitions in The Legal 500 UK 2022 Edition
Highly Regarded Technology Partner Joins Baker Botts’ Corporate Practice in Dallas
Partner Cynthia Cole Elected to Leaderxxchange Advisory Board
Baker Botts’ Transactional Practices Shine in Legal 500 and Chambers USA Rankings
Baker Botts Continues Ascent Up Legal 500 US Rankings
PacBio v. Oxford Nanopore
Global Legal ChronicleGlobal Legal Chronicle
Court of Appeals for the Federal Circuit Affirms Jury Decision to Invalidate Certain PacBio Patents
Fed. Circ. Backs Oxford Nanopore's DNA Tech IP Trial Victory
Law360Law360
Federal Circuit Denies Retrial to Pacific Biosciences in DNA-Sequencing Patent Dispute
Law StreetLaw Street
Federal Circuit Upholds Delaware Jury's Finding in DNA Sequencing Patent Case
Delaware Business Court InsiderDelaware Business Court Insider
Fed. Circ. Affirms PacBio Loss on its DNA-Sequencing Patent Claims
ReutersReuters
Oxford Nanopore’s Trial Win Over DNA Sequencing Patents Upheld
Bloomberg LawBloomberg Law
Baylor, Gensetix Agree To Drop Cancer Patent Fight For Good
Law360Law360
Law360's 2021 Life Sciences Editorial Board
Law360Law360
Baker Botts Welcomes Prominent Cross-Border M&A Partner in New York
Baker Botts Promotes 19 Lawyers to Special Counsel
Baker Botts Elects 12-Member Partnership Class
Baker Botts’ IP Department Secures Highest Win Rate Nationally in Patent Challenges Over Last Five Years
Supreme Court Asked to Step in Amid Genus Claims Losing Streak
Bloomberg LawBloomberg Law
Baker Botts Continues to Expand West Coast IP Practice with Addition of Prominent Partner
How Will FDA Regulate Disease-Sniffing Dogs?
Update MagazineUpdate Magazine
Full Economic Impact of COVID-19 on Life Sciences Industry Still Uncertain
MedTech IntelligenceMedTech Intelligence
Virus Researchers Race to File Patents Ahead of Research Reveal
Bloomberg LawBloomberg Law
Virus Collaborations Could Create Messy Patent Questions
Bloomberg LawBloomberg Law
Law360's 2020 Life Sciences Editorial Advisory Board
Law360Law360
Pacific Biosciences of California Inc. v. Oxford Nanopore Technologies Inc
Global Legal ChronicleGlobal Legal Chronicle
And the LOTW Runners Up...
Litigation DailyLitigation Daily
Law360's Weekly Verdict: Legal Lions & Lambs
Law360Law360
Del. Jurors Clear Oxford Nanopore In DNA Tech Patent Suit
Law360Law360
Patent Trial Opens Over DNA Tool Used To ID Coronavirus
Law360Law360
Congress in Hot Seat to Fix Patent Law After High Court Denials
Bloomberg LawBloomberg Law
Justices Slam Door On Pleas To Redo Patent Eligibility
Law360Law360
New York-Based Partner Robert Scheinfeld Named Co-Chair of Baker Botts’ Globally Recognized Intellectual Property Department
Law360's Life Sciences Editorial Advisory Board
Law360Law360
Lawmakers Eye Biosimilar-Delay Deals, But None Are Here Yet
Law360Law360
Fed. Circ. Says UK DNA Sequencers Don’t Infringe IP In US
Law360Law360